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Focus
A Holistic Approach to Breast Cancer Research
The incidence of breast cancer in the
United States has more than doubled over
the last three decades, from 1 in 20 in
1960 to 1 in 9 today. And though that 1 in
9 does not refer to any woman's chance of
breast cancer at any given time but rather
to the average lifetime risk of a woman
who lives to age 85, it is nonetheless a for-
midable and frightening statistic, especially
in light ofits relentless climb and its deadly
legacy.
The National Women's Health Net-
work ranks breast cancer as second only to
health care access, exceeding hormone
replacement therapy on its list ofpriorities.
Breast cancer is no less a nemesis to scien-
tists grappling with still elusive causes, pre-
vention, and treatment. As breast cancer
rates rise and congressional interventions
intensify, lawmakers demand to know why
prevention efforts have failed and why cer-
tain geographic areas seem to spawn breast
cancer.
Environmental Studies
The site of highest breast cancer incidence
in the United States lies along the upper
east coast. Alerted by his state's place
among the 10 leading jurisdictions, Con-
gressman Bernie Sanders (I-Vermont)
introduced a bill in 1991 to establish uni-
form statewide breast cancer registries and
earmark money for research to discern why
the northeast and mid-Atlantic regions are
especially prone to develop breast cancer.
That bill was enacted late last year.
Even more recently, Congressman
Henry Waxman (D-California) appended
an amendment to the 1993 National
Institutes of Health reauthorization bill
directing the National Cancer Institute and
NIEHS to launch a study to assess biologi-
cal markers of environmental and other
risk factors contributing to the incidence of
breast cancer in four northeastern counties,
including the two with the highest breast
cancer mortality rates over a 5-year period
during the last decade. The legislation
passed in both houses and is not expected
to encounter any obstacles to enactment.
According to Ripley Forbes, a Waxman
aide involved in putting the legislation
together, the focus of this study is some-
what different from the 10-state investiga-
tion mandated in the Sanders legislation in
that it is "thoroughly local and individual
and is intended to provide a total look,"
accounting on a case-control basis for all
risk factors (endogenous, dietary, and envi-
ronmental), with emphasis on the environ-
mental factors. Forbes noted that the
National Research Council and NIH col-
laborated on specifics of the proposed
study.
Factor Analysis
According to Richard DiAugustine, head
ofthe NIEHS hormones and cancer group,
ovarian sex steroids play an obligatory role
in the evolution of breast cancer. Women
whose ovaries have been removed at an
early age, he observes, "have about the
same rate of breast cancer as men do."
Breast cancer in men is not nonexistent but
the rate is quite low. Last year breast cancer
contributed to an estimated 46,000 deaths
among women and 300 among men.
Estrogen is the singular moving force in
mammary gland development until puber-
ty, after which estrogen and progesterone
are the critical factors in breast cell divi-
sion. "Normal cyclic cell division occurs
every month; breast tissue is constantly
dynamic, which puts the tissue at risk,"
DiAugustine says, pointing to the need for
more research into how sex steroids con-
verge to stimulate growth factors in the
breast. "We need to understand the normal
pathway and then investigate what may be
working to exacerbate it. In animals, the
system doesn't have much tolerance for
insult," he says.
As to other factors that may be instru-
mental in the playing upon the vulnerabili-
ty of breast tissue, DiAugustine comments
that "all doors must stay open," especially
in the face of recent publicity implicating
pesticides. He offers total calorie intake
and exercise as factors affecting estrogen
metabolism that are worthy of closer
scrutiny. The fact thatJapanese women liv-
ing in Japan have a much lower breast can-
cer rate than their own siblings living in
the United States or American women is
an important question, he says. One obvi-
ous question is the relative importance of
the typical Japanese diet, replete in soya-
based products and about 25% lower in
calories than the American diet, compared
to the levels of chemical residues in the
breast tissue ofJapanese women.
The United States is not the only coun-
try that has experienced increased breast
cancer rates and mortality. According to
the findings of David Hoel, head of the
Department of Biostatistics, Epidemiology
and Systems Science at the Medical Uni-
versity of South Carolina, breast cancer
mortality has been rising in industrialized
nations throughout the world over the last
two decades. Most scientists believe that
breast cancer involves a complex interac-
tion ofinternally and externally introduced
factors, all played upon by the element of
time.
Multistage Mechanisms
The development of breast cancer, like
most other cancers, probably requires sev-
eral steps. Exposures to environmental
chemicals may increase risk of breast can-
cer by facilitating one or more of those
steps. For example, some chemicals may
bind irreversibly to DNA, forming a DNA
adduct. If a cell containing this DNA
adduct divides, the damage may be fixed
into the genome as a cellular mutation.
The chance for a chemically induced cellu-
lar mutation is greatest between the ages of
12 and 20, during the time of rapid mam-
mary cell division. Estrogens provide the
stimulus for genetically altered breast cells
to divide more rapidly than normal cells, a
process that eventually causes a tumor.
Therefore, estrogenically active chemicals
(such as DDE, PCBs, and oral contracep-
tives) could increase breast cancer risk by
an exaggerated stimulus ofcell division.
Environmental Carcinogens
Opinions differ on how much each factor
contributes to breast cancer. Former NIH
Director Bernadine Healy told a congres-
sional subcommittee that "pollution
doesn't seem to be a major factor in breast
cancer; even cigarette smoking, which
causes so much cancer, doesn't seem to fig-
ure in this kind. Hormones and diet
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Richard DiAugustine. All doors must stay open in
breast cancer research.
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appear to be the most compelling factors."
She spoke at a hearing convened to air a
Government Accounting Office report that
concluded, "there has been no progress in
preventing" breast cancer in the 20 years
since the national "war against cancer" was
launched in 1971.
At the same hearing, National Research
Council Scholar-in-Residence Devra Lee
Davis pointed to "broad environmental
factors that can stimulate estrogen" as the
place to look for clues to the other 70% or
more of breast cancer cases not predicted
by known risk factors. She likened the
skepticism toward the suggestion that
breast cancer could be caused by certain
environmental carcinogens to that which
greeted early reports that tobacco smoking
causes lung cancer. "A number of serious
scientists," she said, "argued that lung can-
cer could not possibly be caused by smok-
ing because there was no mechanism that
could be imagined. Moreover, others con-
tended that the recorded increases in lung
cancer were chiefly due to improvements
in medical technology that made it easier
to detect."
Davis and "cancer establishment" critic
Samuel Epstein, professor ofOccupational
and Environmental Medicine at the Uni-
versity of Illinois Medical Center in Chi-
cago, have suggested pesticides and other
organic chemicals that concentrate in fat as
targets for scrutiny. In awide-ranging chal-
lenge to NCI priorities and practices,
printed earlier this year in the International
Journal ofHealth Sciences, Epstein decries
the current preoccupation with dietary fat
as a breast cancer risk factor while the "car-
cinogenic contaminants in dietary fat, par-
ticularly pesticides, polychlorinated bi-
phenyls, and estrogens" (added to animal
feed to promote growth) are ignored.
Davis and Epstein cite two recent stud-
ies that bolster the argument for more
research in this area: one published last
year in the Archives ofEnvironmental
Health by University of Michigan investi-
gator Frank Falck showing that some
women with breast cancer had markedly
higher levels of pesticides and PCB res-
idues in their breast tissue than women
with benign fibrocystic breast conditions
and another, published in 1990 in the
Annals ofthe New YorkAcademy ofSciences,
in which Israeli investigators documented a
30% decrease in breast cancer deaths
among premenopausal Israeli women after
allowable pesticide levels in dietary fats
were reduced, despite an overall increase in
fat consumption.
The literature on chemical residues in
breast fat tissue is "confused," comments
NIEHS epidemiologist Walter Rogan.
Different studies uncover higher levels of
one or another agent in the breast tissue of
breast cancer patients, but findings are not
consistent. And though lactation has been
associated with a weak protective effect in
the nursing mother, presumably through
lowering her pesticide burden, there has
been no increased risk imposed on the
daughter attributable to having been
breastfed. The daughters of women who
later develop breast cancer are at no greater
or lesser risk of breast cancer for having
been nursed or not.
Another theory is that background lev-
els of environmental chemicals that act as
estrogens accumulate in breast tissue and
ultimately cause cancer. Rogan calls this
speculation, but adds, "there is evidence
for some degree ofhormonal activity from
exposure" to such chemicals as DDE, the
stable DDT metabolite, which persists in
fat tissue for decades, unlike endogenous
uevra Lee uavis. Estrogen stimulators hold key
to breast cancer.
estradiol with a half-life of 12 hours. "If
you give tiny doses of DDE to a mouse
every day, eventually it will become fully
estrogenized. And women with higher lev-
els of DDE lactate for shorter periods of
time than women with low levels. The
DDE acts like estrogen in opposing pro-
lactin," he says. Indeed, DDE blood levels
were significantly elevated in a dose-
response manner in breast cancer patients
in a study published last April that also
demonstrated a trend toward a PCB associ-
ation with breast cancer. The age pattern
related to increased breast cancer rates,
according to Mary S. Wolff, ofNewYork's
Mount Sinai School ofMedicine, is "con-
sistent with the historical pattern of accu-
mulation oforganochlorine residues in the
environment. However, NIEHS's DiAugus-
tine cautions that if pesticides were potent
enough estrogens to increase breast cancer
rates, endometrial cancer rates would be
soaring.
Endogenous Estrogen
Aside from a genetic propensity for breast
cancer, which accounts for perhaps 5% to
10% ofbreast cancer in the United States,
endogenous estrogen is the most important
intrinsic factor that propels breast cell
growth, both normal and abnormal.
Animal studies have shown that rats ex-
posed to breast cancer-causing chemicals
do not develop tumors in the absence of
estrogen; similarly, chemically induced
oncogenes are dormant in rat mammary
tissue until estrogen is added.
Working with human breast cancer cell
lines, called MCF-7, investigators have
found that estrogen accelerates cell growth
and stimulates the secretion ofgrowth fac-
tors such as transforming growth factor-a
(TGF-oc) that are overexpressed in cancer-
ous breast tissue, while inhibiting the
secretion ofTGF-0, which suppresses
mammary epithelial cell growth. In fact,
enhanced secretion ofTGF-,3 is one plausi-
ble mechanism whereby the antiestrogen
tamoxifen lowers the risk of cancer in the
contralateral breast of breast cancer
patients.
Estrogen production is a central com-
ponent of many known breast cancer risk
factors. Early age at menarche and late age
at menopause, both of which prolong
exposure to ovarian sex steroids in general,
are associated with a higher risk of breast
cancer; conversely, early menopause and
late menarche are linked to lower risk.
Postmenopausal obesity, wherein breast
adipose tissue serves as an estrogen factory,
is also associated with a higher risk of
breast cancer .
According to Jeanne Petrek, assistant
attending surgeon at the Memorial Sloan-
Kettering Cancer Center in New York,
there's been a rise in pregnancy-associated
breast cancer among the growing numbers
of women who delay childbearing until
their late thirties or early forties, but she
believes this observation reflects an age-
related increased risk of breast cancer
rather than a pregnancy-induced phenom-
enon. Some scientists speculate that the
older a woman is, the more likely she is to
harbor tumor cells whose growth would be
stimulated by a pregnancy-enhanced hor-
monal environment. Another mechanism
might involve enhanced breast epithelial
cell division, increasing the chances of
oncogene generation or loss of tumor-sup-
pressor genes, both ofwhich are implicated
in breast cancer.
Interestingly, though early menarche
does not confer a huge disadvantage (onset
at age 11 carries a relative risk of breast
cancer of 1.3 compared to age 16 among
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American women), it represents a striking
differential between American and Asian
women, whose overall breast cancer risk is
four times lower. The average age of
menarche in the United States is 12.8; in
China, for instance, it is 17.
Similarly, the impact of dietary fat
intake on breast cancer risk in women
whose lives are spent within U.S. borders
has yet to be conclusively demonstrated,
but at the international level, the collective
eating habits of countries as a whole com-
pared with other countries correlates with
relative breast cancer risks. The dramatic
rise in breast cancer rates among Asian
women who emigrate to the United States
has fueled the argument that diet is a pow-
erful factor in breast cancer development.
"Large variations in the rates ofbreast can-
cer among countries and over time within
countries and large increases in the rates of
breast cancer among populations migrating
from nations with a low incidence to those
with a high incidence indicate the exis-
tence of major nongenetic determinants of
breast cancer and the potential for preven-
tion," observe collaborating American and
Italian breast cancer specialists in a review
article published last year in the New
EnglandJournalofMedicine.
Time
The potential for prevention may revolve
around the timing of the efforts, just as
timing appears to be a pivotal aspect of
breast carcinogenesis. Whatever burdens
teen pregnancy imposes, a woman who
carries a pregnancy to term before the age
of 18 reduces her risk of breast cancer to
one-third of a woman whose first birth
occurs at age 35 or later. Some investiga-
tors predict a 9% increase in breast cancer
rates attributable to the trend toward
delayed childbearing.
The first term pregnancy is believed to
hasten the completion of breast epithelial
cell differentiation, rendering the breast
less susceptible to disruptive growth forces
and the opportunity for mutation. Indeed,
scrutinizing environmental factors for
potential breast carcinogenicity without
considering the stage of breast develop-
ment at the time of exposure could yield
deceptive information, many scientists cau-
tion.
Animal and epidemiologic studies
reveal an age-related sensitivity to carcino-
genic exposures. For example, exposure to
polycyclic aromatic hydrocarbons, a com-
ponent ofexhaust fumes, at a time ofrapid
division of immature breast epithelial cells
virtually ensures the development ofbreast
cancer in rats. Earlier or later exposure
causes a much lower incidence.
The same age-related phenomenon has





A complex interaction of endogenous and exogenous factors leadsto breast cancer.
exposures to a variety of potential breast
cancer risk factors: cigarette smoking, alco-
hol, radiation, and oral contraceptives.
Epidemiologic studies also suggest that diet
may exert its greatest impact early in life.
One example of age-related sensitivity
is illustrated by a study on smoking and
breast cancer. Cigarette smoking started at
age 25 had no influence on breast cancer
risk, but heavy smoking that began in the
early teens imposed a two- to threefold
greater risk later in life. This effect possibly
is due to the work ofchemical carcinogens
in the smoke acting on time-dependent
cell susceptibility.
Among Japanese females who survived
the atomic bomb, the risk of later breast
cancer was greater with younger age at
radiation exposure. Presumably radiation,
like smoking, is damaging to the DNA.
This damage can be readily fixed into the
genome by the rapid cell division that
occurs in young women. Estrogens stimu-
late these damaged cells to multiply, giving
rise to a tumor.
A similar pattern was documented for
nearly 900 female survivors of Hodgkin's
disease who underwent radiation therapy
at Stanford between 1961 and 1990.
Those who were treated between the ages
of 10 and 19 had a nearly 40-fold in-
creased risk ofbreast cancer between 4 and
22 years after treatment and on average at
15 years; the relative risk was about 15 for
those treated between ages 20 and 29 and
was not elevated at all for those treated
after age 30. A high rate of breast cancer
among young women given radiation ther-
apy for Hodgkin's disease was also report-
ed by physicians at Memorial Sloan-
Kettering Cancer Center who also con-
ducted research with MCF-7 breast cancer
cell lines showing that manipulation of
insulin and estrogen levels modifies cellular
response to radiation.
Radiation treatment for cancer in one
breast has been found to increase the
already elevated risk of cancer in the other
breast by 3%. The radiation dosage that
accompanies lumpectomy procedures is
the same as that used for Hodgkin's
patients, but "you don't see a radiation-
induced risk after menopause," a researcher
at Sloan-Kettering notes.
A role for alcohol in breast cancer has
been suggested by some studies. Several
studies have found an increased risk among
women with a history of having two or
more drinks a day before age 30 or begin-
ning consumption in adolescence. At the
other end of the reproductive cycle, the
possibility of a synergistic effect between
alcohol and estrogen replacement therapy
emerged in the Nurses' Health Study,
Environmental Health Perspectiveswhich found an increased risk of breast
cancer among current estrogen replace-
ment therapy users who also drank alcohol.
Of the different factors, aside from
radiation, exogenous estrogen has received
the most attention as a potential cause of
elevated breast cancer risk due to medically
prescribed regimens. In the case of oral
contraceptives, age at first use and use
prior to first term pregnancy have emerged
as factors that may increase breast cancer
risk in younger women. Epidemiologic
studies suggestive of this age-related vul-
nerability, coupled with its biologic plausi-
bility, have led to calls for caution and fur-
ther research, especially into the lower-dose
formulations that reflect oral contracep-
tives used today, as opposed to the higher
dose products on the market when most of
the studies were done.
Exogenous estrogen in the form of
estrogen replacement therapy also moder-
ately increases breast cancer risk after 10
years ofuse, a finding that led the FDA to
revise estrogen replacement therapy label-
ing to alert long-term users to this possibil-
ity. Still unresolved, however, is the impact
of adding a progestin to the estrogen
replacement therapy regimen, a practice
widely recommended to counter the estro-
gen-associated risk of endometrial cancer
in postmenopausal women. A Scandin-
avian study that implicated adjunctive
progestin in a fourfold increased breast
cancer risk has been criticized for design
flaws. But some investigators point out
that the biology ofbreast cell mitotic activ-
ity, which peaks during the second half, or
luteal phase, of the menstrual cycle after
progesterone kicks in, supports the notion
that estrogen and progesterone may stimu-
late mammary cell proliferation. On the
other hand, timing breast cancer surgery
during the luteal phase of the menstrual
cycle has been found to improve survival in
premenopausal patients in some studies, a
phenomenon variously attributed to the
hormonal milieu or immunologic state at
that time. More studies are in progress on
this issue.
The correlation ofhigher breast cancer
incidence with earlier menarche and taller
stature is widely invoked as reflecting the
influence of nutrition during childhood
and adolescence. An abundance ofcalories,
fat, and protein hastens and enhances
growth and maturation, thereby setting the
stage for later breast cancer. (In animals,
restricted food intake early in life yields a
dramatic decrease in mammary tumors.)
Consistent with this hypothesis are studies
showing higher rates of breast cancer
among Asian women who immigrated to
the United States early in life. Subsequent
generations ofthese immigrants were taller
and also had higher incidences of breast
cancer. However, this finding is being
challenged by results ofmore recent studies
among the same populations suggesting
that breast cancer rates among immigrants
increase regardless of age of arrival to the
United States.
Dietary Fat
Pinpointing dietary elements that may
potentiate breast cancer has been difficult.
Animal and epidemiologic studies suggest
a number ofmacronutrients and micronu-
trients for investigation, but results of
case-control and cohort studies are am-
biguous. In a report last year from the
Nurses' Health Study, lower fat intake was
not found to confer reduced breast cancer
risk. This finding drew immediate respons-
es from the National Women's Health
Network and National Cancer Institute,
both of which pointed out that fat intake
in the study ranged from 27% to 50% of
total calories, not the 20% that will be
studied in NIH's massive Women's Health
Initiative, which will also look at fiber,
fruits, and vegetables. The women's health
advocacy group observed "claiming that
this research negates the relationship
between dietary fat and breast cancer is
tantamount to claiming that since smoking
one pack or three packs of cigarettes per
day both result in lung cancer, smoking is
not related to lung cancer." Among the
findings of an as-yet unpublished joint
U.S.-Finnish study is a positive association
between fat as a percentage ofcalories and
level of daily cholesterol intake and breast
cancer risk.
Though many have long demanded a
government-sponsored low fat/breast can-
cer intervention trial and applaud its
launching, some have said the focus may
be too limited. Breast surgeon Susan Love,
of the University of California-Los
Angeles, observed at a congressional hear-
ing that it would be a good idea to study
the impact of a low-fat diet at puberty,
when it might make more of a difference,
something unaddressed in the Women's
Health Initiative, which involves women
45 and older. Love, like others, questions
whether it is the fat in the diet or the car-
cinogens in the fat that increase breast can-
cer risk.
Louise Brinton, chief of the NCI En-
vironmental Epidemiology Branch, said
she anticipates "interesting findings" from
a case-control study in progress scrutiniz-
ing multiple risk factors, including alcohol
intake, diet, oral contraceptive use, and
genetic factors. The study seeks to gather
information on adolescent as well as adult
dietary patterns, but, Brinton said, "it's
unclear thatt we'l gt that data. It's difficult
to ascertain adolescent diet. The unan-
swered question there is whether diet is
having an effect on endogenous hor-
mones.
The goal of risk factor identification
clearly is "something we haven't yet been
able to do very well-gain insights into the
role ofthe preventable factors, like diet and
medications, which lend themselves to
intervention, unlike other identified factors
such as age at menarche and early familial
breast cancer," Brinton said. Currently, she
added, the one possible mechanism for
prevention in postmenopausal women is
weight loss.
Body Fat
Whatever the significance of dietary fat,
the significance of body fat in post-
menopausal women has been demonstrat-
ed often enough for investigators to advise
preventive actions, especially if the fat is
distributed in the pattern of so-called
android, or apple-shaped, obesity. Wheth-
er weight loss actually lowers breast cancer
risk has yet to be proved, but it has been
reported to reverse the high-risk hormonal
patterns (increased levels of nonprotein-
bound estrogen) associated with this type
ofobesity.
Obesity at the time of breast cancer
diagnosis, defined as 25% above optimal
weight, was also reported last year to be
associated with hastened time to recurrence
after initial treatment, regardless of the
patient's age or menopausal status when
diagnosed. The investigators proposed that
further research be undertaken on the role
that obesity might play in the lower sur-
vival rates among black breast cancer
patients, and they advocated weight con-
trol as ageneral preventive measure.
Weight control, however, is notorious-
ly difficult to achieve. Obesity is among a
list ofknown risk factors Devra Davis says
are really "not amenable to social policies
to change them," however desirable that
might be. Other factors include family his-
tory, age of childbearing, and timing of
sexual maturation. Most investigators who
comment on modifiable risk factors ex-
clude these from serious consideration.
Hormones
The authors ofa review article in the New
EnglandJournalofMedicine (30July 1992)
comment that "prevention may depend on
artificial manipulation of hormones and
growth regulators that underlie the known
risk predictors, such as a woman's age at
the birth of her first child and at meno-
pause." At an NIH workshop on research
opportunities in women's health, investiga-
tors discussed the idea ofhormonal manip-
ulation to delay menarche by a year or two
tO lower breast cancer risk.
Malcolm Pike, chairman of preventive
medicine at the University of Southern
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Susceptibility to breast cancer is determined by
gene BRCAl on chromosome 17.
California School ofMedicine, and his col-
leagues have been evaluating the impact of
gonadotropin-releasing hormone agonist in
women between the ages of 25 and 40 at
high risk for breast cancer. The regimen
they use simulates the hormonal environ-
ment of a woman who has had her ovaries
removed. Pike has also suggested using
tamoxifen instead of standard hormone
replacement therapy for postmenopausal
women with a history of breast cancer or
otherwise at higher risk ofbreast cancer. As
an antiestrogen with weak estrogenic
effects, tamoxifen could be expected to
yield the cardiovascular and bone benefits
of estrogen replacement while averting the
potential cancer risks. The same rationale
underlies the NCI-sponsored tamoxifen
breast cancer prevention trial, which will
involve 16,000 women at high breast can-
cer risk and represents the most ambitious
attempt to manipulate hormonal breast
cancer risk factors.
But some women's health advocates
strongly oppose the trial, pointing to
tamoxifen's documented estrogen-related
side effects as an unjustifiable danger to
otews heath woen ThatPpPpPPpP.PipP taoxfe
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treated for breast cancer does not mean it
will function the same way in a woman
who has never had breast cancer, they say.
"Both breasts of a woman with breast
cancer have been exposed to identical
genetic, reproductive, hormonal, and envi-
ronmental influences. Thus, there is no sci-
entific basis for regarding the contralateral
breast of a woman with breast cancer as a
healthy control," said Adriane Fugh-
Berman, a physician-consultant to the
National Women's Health Network, in
testimony before Congress and the FDA.
Genes
It is the confluence of genetic, reproduc-
tive, hormonal, and environmental influ-
ences that has commanded the interest of
Congress and much of the breast cancer
research community. But the one thread
that appears to be removed from the rest of
the weave is genetic predisposition.
Regarding the question ofwhether any
other risk factors influence the expression
of a breast cancer gene thought to be car-
ried by 1 in 200 women, Sarah Rowell, an
epidemiologist in the laboratory of Mary
Clair King at the University of California
at Berkeley School of Public Health, says,
"to put it simply, no," at least not regard-
ing those women in high-risk families who
inherit the genotype that results in early
breast cancer. Rowell says the gene, which
is called BRCAI and is located within a
very small region of the long arm of chro-
mosome 17, is transmitted through auto-
somal dominant inheritance. "It could also
be," she adds, "that the same gene is
mutated in other women who develop
breast cancer," in which case any circum-
stance that lends itself to acquired gene
mutations could be responsible and there-
fore amenable to preventive measures.
Chromosome 17 is rife with genes
associated with cancer in general and breast
cancer in particular, including the HER-
2/neu oncogene, which is overexpressed in
breast cancer, the metastasis-supressor gene
NM23, the gene that encodes the enzyme
estradiol 17-3 dehydrogenase, the gene
encoding the retinoic acid receptor, and
the gene encoding the tumor-suppressor
protein p53.
The presence of mutant p53 in breast
cancer patients is associated with lower
postoperative survival. A number of envi-
ronmental factors have been found to be
associated with p53 mutation, at least in
regard to several other cancers, including
radon-induced mutations associated with
lung cancer in uranium miners and virus-
induced mutations associated with lym-
phoma in human immunodeficiency viral
Fran Pollner is a freelance writer in Takoma
Park, Maryland.
infection. Overexpression of the HER-
2/neu oncogene, associated with more
aggressive breast and ovarian cancer, is
caused by cell damage and may be amen-
able to targeted therapy with monoclonal
antibodies.
George Lucier, chief of the NIEHS
Laboratory of Biochemical Risk Analysis,
observes that some preventive efforts could
be directed toward early recognition of
genetic mutations and the development of
molecular approaches to block their ex-
pression. This process would also identify
those risk factors that induced the muta-
tions and suggest avenues to avoid them.
Lucier adds that development of effec-
tive prevention and intervention strategies
can only be achieved by increasing under-
standing ofthe hormonal, genetic, dietary,
and environmental factors that affect the
risk of breast cancer. That those risk fac-
tors tend not to act in isolation, but rather
interact to produce an effect, is the premise
from which leading-edge research into
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